Antihypertensives Explained: Beta-Blockers, ACE Inhibitors, and ARBs - Risks, Benefits, and What Really Works

Antihypertensives Explained: Beta-Blockers, ACE Inhibitors, and ARBs - Risks, Benefits, and What Really Works
December 29 2025 Elena Fairchild

When your blood pressure stays too high, doctors don’t just tell you to eat less salt or walk more. They reach for a pill. And for millions of people, that pill is one of three classes: beta-blockers, ACE inhibitors, or ARBs. These aren’t just random drugs - they’re the backbone of hypertension treatment. But here’s the thing: not all of them work the same way, and not all of them are safe for everyone. Some cause a dry cough so bad you can’t sleep. Others make you feel like you’re dragging through molasses. And a few? They could save your life after a heart attack.

How These Drugs Actually Work (No Jargon)

Your body has a system called the renin-angiotensin system. It’s like a pressure regulator. When your blood pressure drops too low, it kicks in to raise it. But in people with high blood pressure, this system is stuck on “high.”

ACE inhibitors - like lisinopril, enalapril, and ramipril - block an enzyme called angiotensin-converting enzyme. That stops your body from making angiotensin II, a chemical that tightens blood vessels. Less angiotensin II = looser vessels = lower pressure. Simple.

ARBs - losartan, valsartan, candesartan - do something similar but smarter. Instead of blocking the enzyme, they block the receptor that angiotensin II uses to tighten blood vessels. It’s like cutting the signal to the lock instead of breaking the keymaker. No angiotensin II can get through, so your vessels stay relaxed.

Beta-blockers - metoprolol, carvedilol, bisoprolol - work differently. They don’t touch the blood vessels. They slow your heart. By blocking beta receptors, they reduce how hard and how fast your heart pumps. That lowers pressure, yes, but it also drains your energy. That’s why people on beta-blockers often say they feel tired, sluggish, or even depressed.

The Cough That Won’t Go Away

If you’ve ever taken lisinopril and started coughing - a dry, scratchy, nighttime cough that doesn’t respond to cough syrup - you’re not alone. About 1 in 5 people on ACE inhibitors get it. It’s not an allergy. It’s a side effect of bradykinin, a chemical that builds up when ACE is blocked. Bradykinin irritates your throat. It’s harmless, but it’s unbearable.

That’s why ARBs became so popular. They don’t cause bradykinin buildup. So no cough. In a 2021 study of over 300,000 patients, people on ARBs were 38% less likely to develop a cough than those on ACE inhibitors. And angioedema - a rare but dangerous swelling of the face or throat - happens less often too.

Real people say it best. On Reddit, one user wrote: “Switched from lisinopril to valsartan after six months of coughing so hard I peed myself. Within two days, it was gone. I felt like I could breathe again.” That’s not an outlier. CVS Health found that 78% of people who quit ACE inhibitors did so because of cough.

Which One Is Best for Your Heart?

Not all high blood pressure is the same. If you’ve had a heart attack, ACE inhibitors are still the gold standard. The SAVE trial in 1992 showed they cut death risk by 19% after a heart attack. The HOPE trial in 2000 showed a 20-25% drop in major heart events. That’s not small. That’s life-changing.

But if you have heart failure with reduced pumping power (HFrEF), things changed in 2014. The PARADIGM-HF trial compared enalapril (an ACE inhibitor) to sacubitril-valsartan (a new combo drug that includes an ARB). The ARB combo didn’t just match it - it beat it. It cut heart failure deaths by 20% and overall deaths by 16%. Now, guidelines say if you qualify, you start with the combo, not the ACE inhibitor.

Beta-blockers? They’re not for everyone with high blood pressure. If you’re young, healthy, and just have high numbers, beta-blockers aren’t the best pick. The INVEST trial showed atenolol led to 16% more strokes than other drugs. But if you have heart failure or you’ve had a heart attack? Carvedilol and bisoprolol can slash your death risk by 30-35%. The difference isn’t just in the drug - it’s in the class. Carvedilol isn’t the same as atenolol.

A person coughing at night with a ghostly cough cloud, beside an old pill with an X and a new glowing pill on the counter.

The Hidden Trade-Offs

Every drug has a price. For ACE inhibitors, it’s the cough. For ARBs, it’s cost - they’re often more expensive than generic lisinopril. But the real cost comes in what they don’t do.

Beta-blockers mess with your metabolism. They can raise triglycerides by 10-15% and drop your “good” HDL cholesterol by 5-10%. That’s bad news if you’re already prediabetic or overweight. They also make you tired. One study found 28% of patients on metoprolol felt too exhausted to work. Switching to nebivolol - a newer beta-blocker - cut that to 14%.

And here’s something most people don’t know: combining an ACE inhibitor with an ARB sounds like a good idea - double the power, right? Wrong. The ONTARGET trial showed it increased kidney failure risk by 38%. That’s not better. That’s dangerous. No doctor should ever prescribe both together for routine high blood pressure.

Who Gets Which Drug - And Why

Doctors don’t just pick a drug at random. They match it to your body.

  • Diabetic kidney disease? ACE inhibitors win. The RENAAL trial showed they reduce protein in urine 21% better than ARBs. That’s critical for protecting your kidneys.
  • Older adults with high blood pressure? ARBs are gaining ground. A 2021 study found ARBs linked to slower cognitive decline. That’s huge for brain health.
  • Post-heart attack? ACE inhibitors still lead. Even with newer drugs, the evidence for ACE inhibitors here is rock-solid.
  • Heart failure? Sacubitril-valsartan is now first-choice if you qualify. If not, ACE inhibitors or ARBs work fine.
  • Just high blood pressure with no other issues? ARBs or calcium channel blockers (like amlodipine) are better than beta-blockers. Beta-blockers don’t protect your brain as well.

Primary care doctors still prescribe ACE inhibitors as first-line in 58% of cases. But cardiologists? They’re already switching. In 2022, 68% of cardiologists said they’d start a new patient on an ARB instead of an ACE inhibitor - just to avoid the cough.

A medical decision tree showing three patients benefiting from different blood pressure medications based on their condition.

What Patients Actually Experience

Numbers tell part of the story. Real people tell the rest.

On Drugs.com, lisinopril has a 5.8 out of 10 rating. 42% of users report cough. 8% quit because of side effects. Losartan? 7.1 out of 10. Only 15% report problems. That’s not a small gap. That’s a life difference.

One man in Toronto wrote: “I was on lisinopril for two years. I couldn’t talk on the phone without coughing. My wife said I sounded like a dying cat. Switched to valsartan. No cough. No fatigue. I feel like myself again.”

Another: “Metoprolol made me so tired I couldn’t play with my kids. I thought I was getting old. Turns out, it was the beta-blocker. Switched to amlodipine. Energy came back in a week.”

These aren’t rare stories. They’re common. And they’re why adherence matters. CVS Health found that 63% of people stayed on ARBs after a year. Only 57% stayed on ACE inhibitors. The reason? Cough. Simple as that.

Dosing and Starting Out

You don’t start high. You start low and go slow.

  • ACE inhibitor: Lisinopril 10 mg once daily. Max dose: 40 mg.
  • ARB: Losartan 50 mg once daily. Max dose: 100 mg.
  • Beta-blocker: Metoprolol succinate 25-50 mg once daily. Max dose: 200 mg.

If you have heart failure, the rules change. Carvedilol starts at 3.125 mg twice a day. You double the dose every two weeks. It takes 12-16 weeks to reach the target. Rushing it can make you worse.

And never, ever stop these drugs cold turkey. Especially beta-blockers. Stopping suddenly can trigger a heart attack. Always talk to your doctor first.

What’s Changing in 2025?

The game is shifting. The FDA approved a new four-drug combo in 2023 for tough-to-treat high blood pressure. It includes valsartan (an ARB), which shows how much ARBs are taking over.

The PRECISION trial, ending in 2025, is comparing ARBs and ACE inhibitors in people over 65. If ARBs prove better for brain health, guidelines will change again.

And the market? ARBs are growing faster than ACE inhibitors. By 2028, they’ll be the most prescribed renin-angiotensin drug for high blood pressure. Not because they’re stronger - but because they’re easier to live with.

But here’s the bottom line: ACE inhibitors still save lives after heart attacks. Beta-blockers still prevent death in heart failure. ARBs are the better choice for most people starting out - if you want to avoid the cough and still protect your heart and kidneys.

There’s no single best drug. There’s the best drug for you.